Terns Pharmaceuticals Competitors and Similar CompaniesClear all
Fortrea's competitors and similar companies include Rigel Pharmaceuticals.
 Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). |  Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. | |
Founding Date | Founding Date 2023 | Founding Date 1996 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more | Locations South San Francisco, US HQ |
Employees | Employees 19,000 | Employees 1633% increase |
Valuation ($) | Valuation ($) 1.6 b | Valuation ($) 256 m |
Financial | ||
Revenue (est.) | Revenue (est.) $2.7b (FY, 2025) | Revenue (est.) $294.3m (FY, 2025) |
Net income | Net income ($986.2m) (FY, 2025) | Net income $367m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
163↑ 3% increase
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
View company